| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.028 | 0.6 |